NO801018L - Diagnostisk fremgangsmaate. - Google Patents

Diagnostisk fremgangsmaate.

Info

Publication number
NO801018L
NO801018L NO801018A NO801018A NO801018L NO 801018 L NO801018 L NO 801018L NO 801018 A NO801018 A NO 801018A NO 801018 A NO801018 A NO 801018A NO 801018 L NO801018 L NO 801018L
Authority
NO
Norway
Prior art keywords
cancer
concentration
dna
protein
bleomycin
Prior art date
Application number
NO801018A
Other languages
English (en)
Norwegian (no)
Inventor
Stanley T Crooke
Louis Galvan
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO801018L publication Critical patent/NO801018L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
NO801018A 1979-04-10 1980-04-09 Diagnostisk fremgangsmaate. NO801018L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
NO801018L true NO801018L (no) 1980-10-13

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801018A NO801018L (no) 1979-04-10 1980-04-09 Diagnostisk fremgangsmaate.

Country Status (24)

Country Link
JP (1) JPS55143441A (de)
KR (1) KR830002502A (de)
AR (1) AR222700A1 (de)
AT (1) AT365343B (de)
AU (1) AU536522B2 (de)
BE (1) BE882669A (de)
CH (1) CH644453A5 (de)
DE (1) DE3013837A1 (de)
DK (1) DK149980A (de)
ES (1) ES490396A0 (de)
FI (1) FI801078A7 (de)
FR (1) FR2454099A1 (de)
GB (1) GB2047712B (de)
GR (1) GR67692B (de)
HU (1) HU183122B (de)
IE (1) IE49981B1 (de)
IL (1) IL59772A (de)
IT (1) IT1143135B (de)
LU (1) LU82345A1 (de)
NL (1) NL8002094A (de)
NO (1) NO801018L (de)
PH (1) PH15637A (de)
SE (1) SE8002602L (de)
ZA (1) ZA802141B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
FR2454099A1 (fr) 1980-11-07
BE882669A (fr) 1980-10-06
IL59772A0 (en) 1980-06-30
ES8103380A1 (es) 1981-02-16
AU536522B2 (en) 1984-05-10
GR67692B (de) 1981-09-07
HU183122B (en) 1984-04-28
KR830002502A (ko) 1983-05-30
JPS55143441A (en) 1980-11-08
IE49981B1 (en) 1986-01-22
LU82345A1 (fr) 1980-12-16
ATA195780A (de) 1981-05-15
CH644453A5 (fr) 1984-07-31
ES490396A0 (es) 1981-02-16
IL59772A (en) 1983-05-15
SE8002602L (sv) 1980-12-09
GB2047712A (en) 1980-12-03
IE800693L (en) 1980-10-10
IT1143135B (it) 1986-10-22
AU5719380A (en) 1980-10-16
IT8048370A0 (it) 1980-04-09
FR2454099B1 (de) 1984-01-27
FI801078A7 (fi) 1981-01-01
AR222700A1 (es) 1981-06-15
AT365343B (de) 1982-01-11
ZA802141B (en) 1981-04-29
PH15637A (en) 1983-03-11
GB2047712B (en) 1983-02-23
NL8002094A (nl) 1980-10-14
DK149980A (da) 1980-10-11
DE3013837A1 (de) 1980-10-30

Similar Documents

Publication Publication Date Title
Varnum et al. Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer
Metzgar et al. Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma.
US7763435B2 (en) Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity
US4270924A (en) Diagnostic method for detecting cancer
US4188189A (en) Quantitative testing for vitamin B12
WO2021045180A1 (ja) 胃がんマーカー、及びこれを用いた検査方法
Hansen et al. Electrophoretic analysis of the glycan microheterogeneity of orosomucoid in cancer and inflammation
EP3102593B1 (de) Fluorometrischer immunoassay zum nachweis von anti-dsdna-antikörpern
Kreutzer et al. An immunological turbidimetric method for serum transferrin determination
Moncure et al. Immunological and histochemical evaluation of marrow aspirates in patients with prostatic carcinoma
US20010005582A1 (en) Method and kit for early diagnosis of cancer
US5955287A (en) Method of determining level of biological substances elevated in the presence of cancer and other neoplasms
US4424278A (en) Cancer detection procedure using an acyl carrier protein
JPH0580053A (ja) ヒト子宮体癌細胞の免疫化学的検出方法
Kuriyama et al. Clinical evaluation of γ‐seminoprotein in prostate cancer
Buffone et al. Characterization and evaluation of immunochemical methods for the measurement of fecal α 1-antitrypsin
FI60567C (fi) Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning
IE49981B1 (en) A human serum dna-binding protein and diagnostic test method
US4493898A (en) Method for detecting and monitoring cancer
Knapp Partial Characterisation of an Oncofetal Pancreatic Antigen: Its Role in the Differential Diagnosis and Therapy of Patients with Pancreatic Cancer
RU2039985C1 (ru) Способ диагностики злокачественного заболевания и его рецидива
Gohji et al. Serum basic fetoprotein in patients with renal cell carcinoma
Mustala et al. A New Modification for the Determination of 5-Ydroxy-Indole-Acetic Acid (5HIAA) in Urine Unspecific Nitrosonaphthol Reactions and Their Elimination
EP4617664A1 (de) Biomarker-panel zur früherkennung von krebs
KR101403019B1 (ko) 폐암 진단용 마커